SIRS criteria in prediction of septic shock in hospitalized patients with hematologic malignancies

Cancer Biology and Therapy

Volumn 8, Issue 12, 2009, Pages 1101-

  Ibrahim, Sulfi ^a   Claxton, David F ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Hematologic; Hematology; Infection; Leukemia; Malignancy; Prediction; Sepsis; SIRS

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ALLOGENEIC STEM CELL TRANSPLANTATION; BACTERIAL INFECTION; FEVER; HEMATOLOGIC MALIGNANCY; HOSPITALIZATION; HUMAN; HYPOTHERMIA; LEUKOCYTE COUNT; LEUKOCYTOSIS; LEUKOPENIA; MORBIDITY; MORTALITY; NOTE; RISK FACTOR; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TACHYCARDIA; TACHYPNEA;

EID: 68049133139     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.8.12.8732     Document Type: Note

References (4)

1. Pajman D, Moss M. The Epidemiology of Sepsis in Patients with Malignancy. Chest 2006; 129:1432-6.
2. Williams MD, Braun LA, Cooper LM, Johnston J, Weiss RV, Qualy RL, et al. Hospitalized cancer patients with severe sepsis: Analysis of incidence, mortality and associated costs of care. Crit Care 2004; 8:291-8.
3. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal directed therapy in severe sepsis and septic shock. N Engl J Med 345:1368-77.
4. Mato A, Luger S, Heitjan DF, Mick R, Halpern SD, Shah PD, et al. Utility of the systemic inflammatory response syndrome (SIRS) criteria in predicting the onsest of septic shock in hospitalized patients with hematologic malignancies. Cancer Biol Ther 2009; 8:1095-100.